• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中国-老挝边境地区恶性疟原虫对七种抗疟药的敏感性]

[Sensitivity of Plasmodium falciparum to seven antimalarials in China-Laos border].

作者信息

Yang H, Liu D, Dong Y, Yang P, Liu R, Zhang B, Zhang C

机构信息

Institute of Malaria Prevention and Treatment of Yunnan Province, Simao.

出版信息

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1995;13(2):111-3.

PMID:7554157
Abstract

The sensitivity of P. falciparum to chloroquine (CHL), piperaquine (PIP), artesunate (ATS), dihydroartemisinine (DAT), artemether (ATM), arteether (ATE) and pyronaridine (PRN) were assayed by in vitro microtechnique in China-Laos border in 1992. The resistance rates of isolates from the south of Yunnan of China in the border were 97.0%, 96.4%, 12.5%, 16.0%, 6.3% and 34.5%, respectively; ID50 were 119.0, 320.0, 7.2, 5.4, 295.0, 74.4 and 31.9 nmol/L, ID95 were 625.0, 2426.0, 42.2, 36.6, 767.0, 371.1 and 325.2 nmol/L. The resistance rates of isolates from the north border of Laos were in order 9/10, 8/10, 1/5 to CHL, PIP, PRN, ID50 were 114.0, 166.9, 16.4 nmol/L, ID95 were 570.0, 631.1 and 107.7 nmol/L. All the isolates from Laos were sensitive to ATS, DAT, ATM and ATE. ID50 were 5.0, 4.4, 91.6 and 56.7 nmol/L, ID95 were 23.4, 11.1, 3276.1 and 223.9 nmol/L, respectively. The results indicate that P. falciparum in the border was highly resistant to CHL and PIP, while most of the isolates were susceptible to the other 5 of the above-mentioned drugs. A comparison between the isolates from China and Laos showed that there was no significant difference in resistance degree to CHL but the sensitivity of isolates from China to other 6 drugs was lower than those from Laos.

摘要

1992年在中国-老挝边境采用体外微量技术测定了恶性疟原虫对氯喹(CHL)、哌喹(PIP)、青蒿琥酯(ATS)、双氢青蒿素(DAT)、蒿甲醚(ATM)、蒿乙醚(ATE)和咯萘啶(PRN)的敏感性。中国云南边境地区南部分离株的耐药率分别为97.0%、96.4%、12.5%、16.0%、6.3%和34.5%;半数抑制浓度(ID50)分别为119.0、320.0、7.2、5.4、295.0、74.4和31.9纳摩尔/升,95%抑制浓度(ID95)分别为625.0、2426.0、42.2、36.6、767.0、371.1和325.2纳摩尔/升。老挝边境北部分离株对氯喹、哌喹、咯萘啶的耐药率依次为9/10、8/10、1/5,ID50分别为114.0、166.9、16.4纳摩尔/升,ID95分别为570.0、631.1和107.7纳摩尔/升。老挝所有分离株对青蒿琥酯、双氢青蒿素、蒿甲醚和蒿乙醚均敏感。ID50分别为5.0、4.4、91.6和56.7纳摩尔/升,ID95分别为23.4、11.1、3276.1和223.9纳摩尔/升。结果表明,边境地区的恶性疟原虫对氯喹和哌喹高度耐药,而大多数分离株对上述其他5种药物敏感。中国和老挝分离株之间的比较表明,对氯喹的耐药程度无显著差异,但中国分离株对其他6种药物的敏感性低于老挝分离株。

相似文献

1
[Sensitivity of Plasmodium falciparum to seven antimalarials in China-Laos border].[中国-老挝边境地区恶性疟原虫对七种抗疟药的敏感性]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1995;13(2):111-3.
2
[Sensitivity in vitro of Plasmodium falciparum to chloroquine, pyronaridine, artesunate and piperaquine in south Yunnan].[云南南部恶性疟原虫对氯喹、咯萘啶、青蒿琥酯和哌喹的体外敏感性]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1992;10(3):198-200.
3
[In vitro sensitivity of Plasmodium falciparum isolates from China-Myanmar border region to chloroquine, piperaquine and pyronaridine].[中国-缅甸边境地区恶性疟原虫分离株对氯喹、哌喹和咯萘啶的体外敏感性]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2012 Feb 29;30(1):41-4.
4
In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas.中国-缅甸和中国-老挝边境地区恶性疟原虫对八种抗疟药的体外敏感性
Southeast Asian J Trop Med Public Health. 1997 Sep;28(3):460-4.
5
[Assay of sensitivity of Plasmodium falciparum to chloroquine, amodiaquine, piperaquine, mefloquine and quinine in Yunnan province].[云南省恶性疟原虫对氯喹、氨酚喹、哌喹、甲氟喹和奎宁的敏感性测定]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999;17(1):43-5.
6
[Effect of pyronaridine, mefloquine and quinine on artesunate-sensitive and artesunate-resistant Plasmodium falciparum].[咯萘啶、甲氟喹和奎宁对青蒿琥酯敏感及耐药恶性疟原虫的作用]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2000;18(1):5-7.
7
[Effects of artesunate, pyronaridine and hydroxypiperaquine on chloroquine-sensitive and chloroquine-resistant isolates of Plasmodium falciparum in vitro].青蒿琥酯、咯萘啶及羟基哌喹对体外培养的氯喹敏感及氯喹抗性恶性疟原虫分离株的作用
Zhongguo Yao Li Xue Bao. 1988 Jan;9(1):83-6.
8
[In vitro sensitivity of Plasmodium falciparum to chloroquine, piperaquine, pyronaridine and artesunate in Yuxi prefecture of Yunnan province].云南省玉溪市恶性疟原虫对氯喹、哌喹、咯萘啶和青蒿琥酯的体外敏感性
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1998;16(6):460-2.
9
[In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].[云南南部恶性疟原虫对甲氟喹、奎宁、阿莫地喹、氯喹、咯萘啶及磺胺多辛/乙胺嘧啶的体外敏感性]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1994;12(2):140-2.
10
[Comparison of sensitivity of artesunate-sensitive and artesunate-resistant Plasmodium falciparum to chloroquine and amodiaquine].青蒿琥酯敏感和耐药恶性疟原虫对氯喹和氨酚喹敏感性的比较
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999;17(6):353-5.

引用本文的文献

1
Genetic characteristics of P. falciparum parasites collected from 2012 to 2016 and anti-malaria resistance along the China-Myanmar border.2012 年至 2016 年间从中缅边境采集的疟原虫寄生虫的遗传特征和抗疟耐药性。
PLoS One. 2023 Nov 10;18(11):e0293590. doi: 10.1371/journal.pone.0293590. eCollection 2023.
2
In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes.中缅边境地区恶性疟原虫分离株对哌喹的体外敏感性及候选基因多态性的相关性研究。
Antimicrob Agents Chemother. 2013 Apr;57(4):1723-9. doi: 10.1128/AAC.02306-12. Epub 2013 Jan 28.
3
Review of pyronaridine anti-malarial properties and product characteristics.
吡喹酮抗疟特性和产品特征综述。
Malar J. 2012 Aug 9;11:270. doi: 10.1186/1475-2875-11-270.
4
Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981-2006.1981 - 2006年中国云南省恶性疟原虫氯喹耐药性监测
Acta Trop. 2008 Oct;108(1):44-9. doi: 10.1016/j.actatropica.2008.08.010. Epub 2008 Sep 6.
5
Piperaquine: a resurgent antimalarial drug.哌喹:一种重新兴起的抗疟药物。
Drugs. 2005;65(1):75-87. doi: 10.2165/00003495-200565010-00004.
6
Combination therapy for malaria: the way forward?疟疾的联合疗法:未来之路?
Drugs. 2002;62(9):1315-29. doi: 10.2165/00003495-200262090-00003.